Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. It is commonly known that elevated blood serum uric acid (UA) levels is the cause of a number of chronic diseases, such as gout, as well as osteoarthritis and uric acid nephritis. As a rule, prolonged hyperuricemia is accompanied by severe skin manifestations, such as pruritus, erythema, and hypersensitivity. However, the use of drugs to correct hyperuricemia, obviously, does not solve this problem. However, as known, a number of plant extracts effectively enhance the UA clearance, helping to reduce its concentration in blood serum and tissues. Objective. Evaluation of the effectiveness of the herbal composition on the blood serum UA level in patients with initially elevated UA levels. Methods. The study involved patients with elevated serum UA levels (more than 350 pmol/l in women and 415 pmol/l in men). A total of 109 patients aged 45-65 years were examined, including 47 men (Group 1) and 62 women (Group 2). Patients kept a routine diet during the study. A plant composition consisting of micronized leaves of meadowsweet (Filipindula ulmbria) and white birch (Bitula), as well as aspen bark (Pupulus tremula), was used per os at a dose of 500 mg for 30 days. Results. Taking this herbal composition for a month made it possible to significantly reduce the UA level both in men and women. Characteristically, this effect persisted 1 month after the end of treatment. Simultaneously with the decrease in UA level, there were positive significant changes in triglyceride and blood sugar levels in patients with initial hypertriglyceridemia and hyperglycemia. Almost 90% of patients indicated the disappearance of such manifestations as itching, erythema and hypersensitivity, 55% - a decrease in the size of tophi. The effect was observed regardless of the location and extent of skin changes. Conclusion. A plant composition based on meadowsweet (Filipindula ulmbria), white birch (Bitula) and aspen (Pуpulus tremula) can be recommended for use as a component of functional nutrition or as an independent herbal preparation in patients with elevated UA levels, metabolic syndrome and gout.

Full Text

Restricted Access

About the authors

Evgeny I. Vereshchagin

Novosibirsk State Medical University

Email: eivv1961@gmail.com
Vereshchagin, Doctor of the Highest Qualification Category, Dr. Sci. (Med.), Professor, Head of the Department of Anesthesiology and Intensive Care n.a. Professor I.P. Vereshchagin Novosibirsk, Russia

E. V Svechnikova

Novosibirsk State Medical University; Polyclinic № 1 of the Department for Presidential Affairs of the Russian Federation

Novosibirsk, Russia; Moscow, Russia

N. O Artemyeva

Clinic for Preventive and Aesthetic Medicine “Body Project"

Moscow, Russia

References

  1. Emmerson B.T. Effect of oral fructose on urate production. Ann Rheum Dis. 1974;33:276-80.
  2. Fathallah-Shaykh S.A. Cramer MT Uric acid and the kidney Pediatr Nephrol. 2014;29(6):999-1008. doi: 10.1007/s00467-013-2549-x.
  3. King C., Lanaspa M.A., Jensen T., Tolan D.R., Sanchez-Lozada L.G., Johnson R.J. Uric Acid as a Cause of the Metabolic Syndrome. Contrib Nephrol. 2018;192:88-102. doi: 10.1159/000484283.
  4. Young H.R., Yanyan Z., Hyon KCThe epidemiology of uric acid and fructose Semin Nephrol. 201 1;31(5):410-19. Doi: 10.1016/j. semnephrol.2011.08.004.
  5. Pergola G, Cortese F., Termine G., et al. Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? Endocr Metab immune Disord Drug Targets. 2018;18(3):251-59. doi: 10.2174/18715303 18666180212101548.
  6. Abdullah A.R., Hasan H.A., Raigangar V.L. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab Syndr Relat Disord. 2009;7(1):17-22. Doi: 10.1089/ met.2008.0045.
  7. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120:442-47.
  8. Johnson R.J., Nakagawa T, Sanchez-Lozada L.G., et al. Sugar, Uric Acid, and the Etiology of Diabetes and Obesity. Diabetes. 2013;62(10): 3307-15.
  9. Bonakdaran S., Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes Curr Diabetes Rev. 2014;10(2):113-17 doi: 10.2174/15733998106661402281 60938.
  10. Lanaspa M.A., Sanchez-Lozada L.G., Choi YJ., et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287:40732-44.
  11. Rho Y.H., Zhu Y., Choi H.K. The epidemiology of uric acid and fructose. Semin Nephrol. 2011 Sep;31(5):410-19. Doi: 10.1016/j. semnephrol.2011.08.004).
  12. Luk A.J., Levin G.P., Moore E.E., et al. Allopurinol and mortality in hyperuricaemic patientsRheumatology. 2009; 48(7):804-6. doi: 10.1093/rheumatology/kep069.
  13. Ogino K., Kato M., Furuse Y. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail. 2010;3:73-81.
  14. Lee M.H., Graham G.G., Williams K.M., Day R.O. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 2008;31(8):643-65. doi: 10.2165/00002018200831080-00002.
  15. Havlik J., de la Huebra R.G., Hejtmankova K., et al. Xanthine oxidase inhibitory properties of Czech medicinal plants J Ethnopharmacol. 2010;132(2):461-65. Doi: 10.1016/j. jep.2010.08.044.
  16. Gainche M., Ogeron C, Ripoche I., et al. Xanthine Oxidase Inhibitors from Filipendula ulmaria (L.) Maxim. and Their Efficient Detections by HPTLC and HPLC Analyses. 2021;26(7): 1939.
  17. Crone C., Lassen U.V. Mechanism of increased renal urate excretion during administration of salicylic acid. Acta Pharmacol Toxicol. 1955;11(4):362-366. doi: 10.1111/j.1600-0773.1955.tb03271.x.PMID: 13301786) 7.
  18. Oliviero F., Scanu A., Zamudio-Cuevas Y, et al. Anti-inflammatory effects of polyphenols in arthritis J Sci Food Agric. 2018;98(5):1653-59. doi: 10.1002/jsfa.8664.
  19. Shi Y, Williamson G Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, crossover trial Br J Nutr. 2016;115(5):800-6. doi: 10.1017/S0007114515005310.
  20. Chen Y., Zhao Z., Li Y., et al. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. J Phytomedicine. 2021;80:153374. Doi: 10.1016/j. phymed.2020.153374.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies